Public-private collaboration for new life sciences innovation and regional development: the cases of Cambridge and Scotland.
European Planning Studies, 19(3) pp. 403–428.
(Click here to request a copy from the OU Author.
Today, bioscientific research and commercialization are considered to be critical for improving a number of areas of social and economic life. Especially in the sector of human healthcare, the recent developments in new life sciences and biotechnology appear to constitute the main driving force of change. The most important characteristic of the new paradigm of technological change and innovation in life sciences is the close collaboration between all actors involved, including companies and research institutes, public policy initiatives and regional impacts. This paper examines in depth the complex collaborative relationships between public policy, public research and private firms in genomics and biotechnology, focusing on the cases of Cambridge and Scotland. On the basis of empirical evidence, it is argued that although these relationships are uneven and contradictory in both regions, they play significant roles in building firm-based and policy-making capabilities. Therefore, public–private collaborations in genomics and biotechnology are inevitable for regional innovation and development within the contemporary capitalist knowledge-based economy.
Actions (login may be required)